Prolonging hormone sensitivity in prostate cancer xenografts through dual inhibition of AR and mTOR

por Schayowitz, A, Sabnis, G, Goloubeva, O, Njar, V C O, Brodie, A M H
Publicado 2010

A critical analysis of the COMPASS trial with respect to benefit-risk assessment using the numbers needed to treat: Applicability and relevance in Indian patients with stable cardi...

por Kerkar, P., Bose, D., Nishandar, T., Sabnis, G., Kumar, D., Thatte, U.M., Gogtay, N.J.
Publicado 2018

Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth

por Patel, J B, Mehta, J, Belosay, A, Sabnis, G, Khandelwal, A, Brodie, A M H, Soprano, D R, Njar, V C O
Publicado 2007